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Abstract Janus kinase/signal transducer and activator of tran-
scription (JAK/STAT) signalling is essential but not su⁄cient
for full responses to the interferons (IFNs), most cytokines and
some growth factors. The IFN-Q and interleukin-6 (IL-6) re-
sponse pathways have been used as model systems to investigate
both the signals involved and their organisation. Activated
STAT1 di¡uses freely in the cytoplasmic and nuclear compart-
ments of the cell providing a ‘random walk’ element in the IFN-
Q response. Completely foreign chimeric receptors and, remark-
ably, in the absence of STAT3, the endogenous IL-6 receptor
can e⁄ciently mediate an IFN-Q-like response. Accordingly all
of the signals required for an IFN-Q response can be generated
through physiological levels of a foreign ligand. JAK/STAT
signalling, therefore, appears ‘soft-wired’, modular and highly
£exible with substantial overlap between di¡erent response path-
ways. The data are consistent with a generic or ‘core’ set of
signals from JAK/receptor complexes with ‘add-on’ modulation
through speci¢c receptor motifs. The cellular background likely
profoundly a¡ects the nature of the response.
2 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The interferons (IFNs) and the interleukin-6 (IL-6) family
of cytokines (including IL-6 and oncostatin M (OSM) used
here) activate Janus kinase/signal transducer and activator of
transcription (JAK/STAT) signalling through distinct type II
and I cytokine receptors (reviewed [1,2]). For IFN-Q signalling
occurs through IFN-Q receptor subunits 1 and 2 (IFNGR1
and 2) and characteristically triggers prolonged STAT1 acti-
vation. The internal membrane-proximal JAK1 and JAK2
binding domains of IFNGR1 and 2 and the distal Y440
STAT1 recruitment motif of IFNGR1 are generally accepted
to be essential for activity (Fig. 1 and reviewed [3]). For IL-6,
signalling occurs through dimerisation of the common gp130
signal transduction subunit of the IL-6 family of cytokine
receptors (Fig. 1 and reviewed [4,5]). OSM can induce signal-
ling through gp130 heterodimerisation with the closely gp130-
related OSM or leukaemia inhibitory factor receptor subunits.
In response to IL-6 and OSM, JAK1, JAK2, Tyk2, STAT1
and STAT3 are all activated, the JAKs through a conserved
membrane-proximal binding domain and the STATs through
four more distal tyrosine motifs [6,7]. JAK1 and STAT3 play
major roles in IL-6/OSM response(s) [8]. On ligand binding in
both the IFN-Q and the IL-6/OSM systems there is receptor
rearrangement/dimerisation/oligomerisation with auto- and
trans-phosphorylation/activation of the pre-associated JAKs,
phosphorylation of tyrosine motifs in the receptor subunits,
recruitment or reassortment of associated STATs which, on
tyrosine phosphorylation by the JAKs, are released, dimerise,
migrate to the nucleus and, with or without additional factors,
activate transcription (Fig. 1). At some point in the activation
cascade the ability of the STATs to induce transcription is
enhanced by serine phosphorylation through mitogen-acti-
vated protein (MAP) kinase (STAT3) or yet to be identi¢ed
(STAT1) kinase(s) (e.g. [9,10]).
The essential nature of JAK/STAT signalling for the IFNs,
most cytokines and some growth factors has been unequivo-
cally established by work on mutant cell lines and knock-out
mice. The di¡erent ligands activate JAK/STAT and additional
signalling pathways in a modular fashion through di¡erent
JAK/receptor domains. There also appear to be alternative
activators of the STATs, additional JAK-mediated pathways
and cross-talk between the di¡erent pathways. The JAKs have
a number of conserved protein domains that likely mediate
the protein^protein interactions governing their response to
di¡erent ligands, cross-talk and cell type speci¢city (reviewed
[11]). JAK speci¢city appears to be determined mainly by
protein^protein interaction rather than by any exquisite sub-
strate speci¢city of the kinase domains (e.g. [12]). For di¡erent
cytokines the JAKs can also signal through insulin receptor
substrate 1, phosphatidylinositol 3-kinase (PI3-kinase) and the
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extracellular signal-regulated kinase (ERK)1/2 and p38 MAP
kinase pathways (e.g. [13^16], reviewed [17]) and additional
JAK functions are required for the class II human leukocyte
antigen and antiviral responses to IFN-Q [18,19]. Accordingly,
for most cytokines and some growth factors JAK/STAT sig-
nalling is essential but not su⁄cient. Additional signalling
pathways are required, for example, for a full IFN-Q response.
Our recent concern has been to de¢ne the minimum signal-
ling requirements for an IFN-Q response and to determine
how these are organised within the cell. One approach has
been through the use of chimeric receptors. Work with these
has led to the observation that a minimal completely foreign
chimeric receptor can mediate an IFN-Q-like response. This
prompted the observation that, in the absence of STAT3,
IL-6 also mediates an IFN-Q-like response. These data togeth-
er with those demonstrating the free di¡usion of activated
STAT1^green £uorescent protein (GFP) will be brie£y re-
viewed together with their implications for the nature of the
signalling pathways involved.
2. STAT1 from the membrane to the DNA
2.1. IFN signalling is not dependent on an intact cytoskeleton
For IFN-K/L and IFN-Q signalling, STAT1 activation and
translocation to the nucleus and the induction of a represen-
tative set of IFN-inducible genes (ISGs) are independent of
the actin cytoskeleton or microtubules [20].
2.2. Free di¡usion of activated STAT1
The construction and characterisation of a functional
STAT1^GFP, the behaviour of which is indistinguishable
from native STAT1, was ¢rst described by Ko«ster and Hauser
[21]. The STAT1^GFP e⁄ciently complements STAT1-nega-
tive U3A cells. When stably expressed at comparable levels to
endogenous STAT1, the STAT1^GFP is comparably tyrosine-
phosphorylated/activated, shows comparable DNA-binding
activity and is e⁄ciently translocated to the nucleus in re-
sponse to IFN-Q stimulation [20]. In IFN-Q-treated and con-
trol cells both activated (tyrosine-phosphorylated) and non-
activated cytoplasmic STAT1^GFP show high energy-inde-
pendent mobility comparable to that of freely di¡usible
GFP. All activated STAT1 molecules pass through a given
laser-de¢ned ‘cross-section’ of the cytoplasm every few min-
utes. Indeed, the results of an extensive £uorescence inactiva-
tion on photobleaching and £uorescence recovery after photo-
bleaching analysis of the behaviour of STAT1^GFP are
entirely consistent with a random walk model for movement
of activated STAT1 from the plasma membrane to the nuclear
pore complex [20]. An immobile (non-di¡usible) fraction of
STAT1^GFP was not detected and can be excluded down to a
level of approximately 1% of the total STAT1^GFP. Never-
theless it remains possible that at any given instant in time a
very small percentage (6 1%) of the STAT1^GFP could be
transported directionally to the nuclear pore. Access to any
such putative transport system would, however, have to be
available to freely di¡using, randomly distributed, activated
STAT1^GFP [20]. In this model the putative translocation
system would conceptually be an extension of the nuclear
pore^importin complex, with random access of STAT1^GFP
through free di¡usion after release from the receptor. Highly
dynamic interactions of the activated STAT1 with cytoplas-
mic protein complexes remain perfectly possible [22,23]. Such
interactions would not, however, necessarily confer direction-
ality upon the movement of STAT1. Nuclear STAT1^GFP
showed similar high mobility, with exclusion from nucleoli,
consistent with high rates of association/dissociation of
STAT1^DNA and/or STAT1^protein complexes in the nucle-
oplasm of the cell [20]. The dynamic nature of transcription
complexes is discussed more extensively below. Meanwhile
work designed to (i) de¢ne the minimum signalling require-
ments for an IFN-Q response and (ii) test the interchangeabil-
Fig. 1. Schematic representation of JAK/STAT signalling through
the IL-6 and IFN-Q receptors.
Fig. 2. Schematic representation of the Epo/gp130-based chimeric
receptors. All chimeras have the extracellular region of the Epo re-
ceptor (orange) and the transmembrane and full-length or truncated
internal domains of the gp130 subunit of the IL-6 receptor (yellow).
Tyrosine residues in the intracellular region of gp130 are depicted as
black or blue lines, box 1/2 motifs as purple boxes and Flag tags as
red triangles. Chimeras with the full-length intracellular gp130 (Eg),
a truncated gp130 (EgvB) and a truncated gp130 with added tyro-
sine motifs from the human IFNGR1 (Y440) or gp130 (Y905), re-
spectively, are shown.
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ity of the components in di¡erent response pathways led to
the conclusion that a completely foreign receptor can mediate
an IFN-Q response.
3. A completely foreign chimeric receptor can mediate an
IFN-Q-like response
A tripartite receptor comprising the external region of the
erythropoietin (Epo) receptor, the transmembrane and JAK-
binding domain of the gp130 subunit of the IL-6 receptor and
a seven amino acid STAT1 recruitment ‘Y440’ motif from the
IFNGR (Fig. 2) can e⁄ciently mediate an IFN-Q-like re-
sponse. An analogous completely foreign receptor in which
the Y440 motif is replaced by the Y905 motif (Fig. 2) from
gp130 also mediates an IFN-Q-like response, although slightly
less e⁄ciently [24]. Accordingly it would appear that there is
nothing uniquely required that is speci¢c to the Y440 motif.
Interestingly, these systems also provide us with a rather
dramatic, if somewhat frustrating, example of cross-talk in
the form of receptor cross-phosphorylation. The IFNGR is
rapidly cross-phosphorylated through the endogenous OSM,
IL-6 and IFN-K/L receptors and the Epo/gp130 receptor chi-
meras utilised here. As yet we have completely failed to estab-
lish any substantial physiological signi¢cance for this really
rather striking phenomenon. Reciprocal phosphorylation of,
for example, gp130 and the chimeric receptors in response to
IFN-Q was not, incidentally, observed. It remains possible that
in a dynamic receptor complex an appropriate conformation
for the activation of JAKs and receptor phosphorylation may
not, in the absence of appropriate ligand, sequentially assume
the conformation required for e¡ective signalling. In short,
cross-recruitment/phosphorylation of the IFNGR through
the chimeric receptors is observed in these systems. Very im-
portantly, however, it is not required for the IFN-Q-like re-
sponse. Crucially, an IFN-Q-like response through the chimer-
ic receptors is also seen in cells completely lacking an IFNGR
(¢gs. 7 and 8 in [24]). This last result, together with further
controls, additionally rules out any possibility that the IFN-Q-
like response through the chimeric receptors is secondary to
the production of endogenous IFNs.
Taking this one stage further it was obvious from a com-
parison of the activation of STATs 1 and 3 by IL-6 versus
that of STAT1 by IFN-Q (Fig. 1) to ask if, in the absence of
STAT3, IL-6 can mediate an IFN-Q-like response.
4. In the absence of STAT3 IL-6 mediates an IFN-Q-like
response
The biological responses to stimulation through the IL-6
and IFN-Q receptors are completely di¡erent. Remarkably,
in mouse embryo ¢broblasts (MEFs) lacking STAT3, IL-6
e⁄ciently mediates an IFN-Q-like response, including pro-
longed STAT1 activation, the induction of an extensive set
of ISGs, the expression of class II major histocompatibility
complex (MHC) antigens and an antiviral state [25]. Similar
results were obtained in more than one clone of STAT3-neg-
ative cells. On reintroduction of STAT3, IL-6 no longer medi-
ated an IFN-Q-type response. Multiple controls established
that the IFN-Q-like response was not through the induction
of endogenous IFNs [25]. The results with the chimeric recep-
tors just discussed make it unlikely that the Q-like response
re£ects a requirement for receptor cross-phosphorylation. It is
more likely that it re£ects a high degree of overlap in the
signals generated through the IFN-Q and IL-6 receptors per
se. IL-6 and IFN-Q are known to activate multiple common
pathways in addition to the STATs, including those for
STAT1 Ser727 phosphorylation and the PI3-kinase/Akt, and
MKK1/ERK1 and 2 and p38 MAP kinase pathways (re-
viewed [17]), all of which are in fact activated by both ligands
in both the wild-type and STAT3-negative MEFs. Consistent
with this, the activation of STAT1 is essential but not su⁄-
cient, for example, for a full IFN-Q response [19]. All of the
pathways necessary for a full response must, however, be
activated through the highly disparate IFN-Q and IL-6 recep-
tors in the STAT3-negative cells. This, in turn, is in accord
with the concept of a generic or ‘core’ set of signals from
JAK/receptor complexes with ‘add-on’ modulation through
additional receptor motifs and cellular background.
These data together with those for the chimeric receptors
argue strongly for modular JAK/STAT signalling and against
any permanent rigid structural organisation for the ‘pathways’
involved. They emphasise the likely high degree of overlap
between the signals generated from disparate JAK^receptor
complexes and show that relatively subtle changes in such
complexes and the cellular background can profoundly a¡ect
the response.
5. The nature of the signalling pathways
The major conclusions one can reach from the above work
concerning the nature/organisation of the IFN-Q response
pathways are summarised in Table 1. IFN-Q signalling is in-
dependent of the cytoskeleton. We know from the work with
the STAT1^GFP that, ¢rst, activated STAT1 di¡uses freely in
the cytoplasmic and nuclear compartments of the cell and,
second, the movement of STAT1 is extremely rapid in relation
to the size of the cell. It is generally accepted that the activa-
tion of STAT1 is essential but not su⁄cient, additional signals
are required for a full IFN-Q response. From the chimera
work we can conclude that a minimal completely foreign re-
ceptor lacking the receptor internalisation/endocytosis motif
[26] can e⁄ciently mediate an IFN-Q-type response. Accord-
ingly despite intriguing reports of translocation of IFN-Q [27]
and IFNGR complexes [28] to the nucleus and results impli-
cating endosomal transport in STAT translocation [23,29] it
would appear unlikely that these are essential for an IFN-Q
response in the human and mouse cell systems with which we
are working. Similarly despite signi¢cant levels of receptor
cross-phosphorylation, the results with the minimal chimeric
receptor in IFNGR-negative cells excludes any requirement
for such cross-phosphorylation for the IFN-Q-like response
Table 1
Characteristics of JAK/STAT1 pathway in response to IFN-Q
1 JAK/STAT1 signalling is independent of the cytoskeleton
(receptor internalisation and endocytosis)
2 Activated STAT1 di¡uses freely in cytoplasmic and nuclear
compartments
3 Movement of STAT1 is rapid relative to the size of the cell
4 STAT1 activation is essential but not su⁄cient; additional
signals are required
5 In wild-type or IFNGR-negative cells a completely foreign
chimeric receptor can mediate an IFN-Q-like response, as
can IL-6 working through the endogenous IL-6 receptor in
the absence of STAT3
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through the receptor chimeras. Finally, in the absence of
STAT3 IL-6 mediates an IFN-Q-like response. Accordingly,
not just STAT1 but all of the signals required for an IFN-Q-
like response (including the induction of class II MHC antigens
and an antiviral state) can be generated through physiological
levels of a completely foreign ligand working through normal
endogenous levels of a completely foreign receptor. This is an
interesting and unexpected result.
We can, therefore, reach a number of conclusions with re-
spect to the nature of JAK/STAT signalling in the IFN-Q
response. Modular signalling through cytokine and growth
factor receptor complexes is generally accepted, as indeed is
the likelihood of substantial overlap in the signals generated.
Results from microarray analyses have emphasised such over-
lap in the expression pro¢les observed in response to di¡erent
growth factors (e.g. [30]). It is the degree of overlap, possibly
total, for the IL-6, IFN-Q and chimeric receptors which is
surprising. Accepting modularity and overlap the data are at
least consistent with a ‘core’ set of ‘generic’ JAK/receptor
signals with ‘add-on’ modulation through additional receptor
motifs to give receptor type speci¢city and cellular back-
ground to give cell type speci¢city. It is particularly intriguing
that analogous ‘core’ signalling has been proposed by Ihle and
co-workers from an analysis of the responses observed
through modi¢ed Epo receptors in transgenic mice [31]. The
cellular background likely plays a major role. The switch from
an IL-6 to an IFN-Q response in the absence of STAT3 may
be an extreme example, but so profound a change in response
to the presence or absence of a single transcription factor
emphasises the potential for di¡erent cell types to play di¡er-
ent tunes in response to a given signal. Given that potential it
would be amazing if Mother Nature does not make substan-
tial use of it. Indeed recent custom macroarray analysis of
samples from primary peripheral blood mononuclear cells, T
cells and dendritic cells and a number of cell lines established
substantial cell type and donor speci¢city in the expression
pro¢les obtained [32].
In addition, although the pathways have apparently ‘hard-
wired’ components ^ the nuclear pore, for example, for
STAT1 ^ the free di¡usion component and, importantly, the
chimera and IL-6 results suggest that STAT1 signalling is
‘soft’ rather than ‘hard ’-wired. The terms soft- and hard-
wired appear intuitively understandable and singularly appro-
priate and are o¡ered for the bene¢t of those who ¢nd them
so. For those to whom these terms are an unintelligible anath-
ema, one can only reiterate that these pathways require no
¢xed or ‘permanently’ organised three-dimensional structure
to deliver a particular set of signals from a particular receptor
to a particular set of genes. Provided the correct set of signals
are activated it does not seem to matter, within reason, where
or how this occurs ^ the signals will get there anyway. On this
soft-wired model speci¢city would be provided by highly dy-
namic protein^protein (or protein^DNA) interactions which
e¡ectively target (although trap might be a more appropriate
word conceptually), the signal to an appropriate site ^ the
nuclear pore, governing transfer to the nucleus, or appropriate
higher transcription complexes within the nucleus.
In the above the nuclear pore has been presented as an
example of ‘hard’ wiring, but this too may be envisaged to
involve multiple weak interactions between transport recep-
tors and nuclear core components which concentrate the re-
ceptor^cargo complexes in the vicinity of the pore and facil-
itate di¡usion through it (reviewed [33]). There is no doubt,
however, that the nuclear membrane provides an e¡ective
barrier to the free di¡usion of STAT1 [20] and although trans-
port through the pore may ultimately be by di¡usion, the pore
itself is likely stable and confers directionality. The highly
dynamic state of higher transcription complexes has been em-
phasised by the very elegant work from the groups of Hager
and Misteli in particular, who have used very di¡erent ap-
proaches to reach a similar conclusion: the formation of
such complexes is surprisingly dynamic and ine⁄cient ([34^
37], reviewed [38]). Indeed it has been likened to the work of a
blind watchmaker [39]. In the nucleus the nucleolus is surpris-
ingly dynamic. There is no nucleolar membrane and its exis-
tence requires ongoing transcription of rDNA. In more gen-
eral terms, there is no active transport system known in the
nucleus. RNA and RNA processing enzymes move by di¡u-
sion. ‘‘Structures visible by microscopy are the products of
function rather than a pre-requisite for it’’ [33]. It is intriguing
to speculate how general this maxim will prove to be.
To end on a lighter note, the cartoon (Fig. 3) represents the
lab’s current favourite view of JAK/STAT1 signalling in re-
sponse to IFN-Q. Jeeps and trains represent two major means
of transport, the ¢rst versatile and £exible, the second direc-
tional and tied to the rails. Thus the jeep represents the freely
di¡using STAT1 in the cytoplasm and nucleus, the train the
directional transport of STAT1 through the highly structured
Fig. 3. The cartoon depicts the two types of ‘pathway’ contributing
to JAK/STAT signalling. The jeep represents the freely di¡using
STATs in the cytoplasm and nucleus; the train, transport through
the structured nuclear pore which joins these cellular compartments.
Together they yield a highly £exible, easily modulated, rapid re-
sponse pathway.
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nuclear pore joining these two compartments. Together they
yield a highly £exible, easily modulated, rapid response sys-
tem.
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